Gadolinium contrast may be risky in kidney disease.
作者信息
Thomson Peter C, Collidge Tara A, Mark Patrick B, Traynor Jamie P
出版信息
BMJ. 2007 Jun 30;334(7608):1335-6. doi: 10.1136/bmj.39254.924641.1F.
Abstract
摘要
相似文献
1
Gadolinium contrast may be risky in kidney disease.钆造影剂在肾病中可能有风险。
BMJ. 2007 Jun 30;334(7608):1335-6. doi: 10.1136/bmj.39254.924641.1F.
2
How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease?肾病科医生应如何处理肾病患者的钆基对比剂成像？
Clin J Am Soc Nephrol. 2008 May;3(3):649-51. doi: 10.2215/CJN.00670208. Epub 2008 Apr 2.
3
[Gadolinium: a true problem for the nephrologists?].
G Ital Nefrol. 2008 Jan-Feb;25(1):3-4.
4
MRI contrast agents may pose risk for patients with kidney disease.磁共振成像（MRI）造影剂可能会给肾病患者带来风险。
JAMA. 2007 Jan 17;297(3):252-3. doi: 10.1001/jama.297.3.252.
5
Cutaneous nodules, pain, and thrombophlebitis as an adverse reaction to gadolinium contrast media.皮肤结节、疼痛和血栓性静脉炎作为钆对比剂的不良反应。
AJR Am J Roentgenol. 1997 Jul;169(1):318-9. doi: 10.2214/ajr.169.1.9207574.
6
Nephrogenic systemic fibrosis in Japan: advisability of keeping the administered dose as low as possible.日本的肾源性系统性纤维化：将给药剂量保持在尽可能低水平的可取性。
Radiology. 2008 Jun;247(3):915-6. doi: 10.1148/radiol.2473072101.
7
Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures.接受冠状动脉手术患者中基于钆的造影剂与肾毒性
Catheter Cardiovasc Interv. 2006 Feb;67(2):175-80. doi: 10.1002/ccd.20592.
8
Can gadolinium be safely given in renal failure?肾衰竭患者能安全使用钆剂吗？
AJR Am J Roentgenol. 1996 Jul;167(1):278-9. doi: 10.2214/ajr.167.1.8659405.
9
[Nephrotoxicity of contrast media in magnetic resonance tomography (MRI)].磁共振成像（MRI）中造影剂的肾毒性
Internist (Berl). 1997 Dec;38(12):1234-5.
10
Gadolinium-based contrast agents and nephrotoxicity.
Catheter Cardiovasc Interv. 2006 Nov;68(5):812; author reply 813. doi: 10.1002/ccd.20929.
本文引用的文献
1
Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.钆增强磁共振成像与肾源性系统性纤维化：肾替代治疗队列的回顾性研究
Radiology. 2007 Oct;245(1):168-75. doi: 10.1148/radiol.2451070353. Epub 2007 Aug 17.
2
Diagnosis of peripheral arterial disease of the lower limb.下肢外周动脉疾病的诊断
BMJ. 2007 Jun 16;334(7606):1229-30. doi: 10.1136/bmj.39244.344664.80.
3
Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review.双功超声、磁共振血管造影和计算机断层血管造影用于有症状下肢外周动脉疾病的诊断和评估：系统评价
BMJ. 2007 Jun 16;334(7606):1257. doi: 10.1136/bmj.39217.473275.55. Epub 2007 Jun 4.
4
Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned.钆双胺相关性肾源性系统性纤维化：放射科医生为何应予以关注。
AJR Am J Roentgenol. 2007 Feb;188(2):586-92. doi: 10.2214/ajr.06.1094.
5
Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?钆——引发肾源性纤维化皮肤病和肾源性系统性纤维化的特定诱因？
Nephrol Dial Transplant. 2006 Apr;21(4):1104-8. doi: 10.1093/ndt/gfk062. Epub 2006 Jan 23.
Zotero 插件